Antitumor capacity of a dominant-negative RET proto-oncogene mutant in a medullary thyroid carcinoma model.

Drosten, M

Antitumor capacity of a dominant-negative RET proto-oncogene mutant in a medullary thyroid carcinoma model. [electronic resource] - Human gene therapy Jul 2003 - 971-82 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1043-0342

10.1089/104303403766682232 doi


Adenoviridae--genetics
Animals
Apoptosis
Carcinoma, Medullary--metabolism
Cell Division
Cell Line, Transformed
Fluorescent Antibody Technique
Genetic Therapy
Genetic Vectors
Humans
Mice
Mice, Nude
Mutation
Proto-Oncogene Mas
Proto-Oncogene Proteins--analysis
Proto-Oncogene Proteins c-ret
Receptor Protein-Tyrosine Kinases--analysis
Thyroid Neoplasms--metabolism
Tumor Cells, Cultured